Pharmaceuticals

Supporting your Pharmaceuticals business

Research and Development in Pharmaceuticals

Typical Qualifying R&D Activities

Researching and developing new drugs or therapies to treat various medical conditions. This involves extensive work in identifying potential drug candidates, synthesizing compounds, conducting preclinical studies, and optimizing pharmacokinetic and pharmacodynamic properties.

Conducting clinical trials to evaluate the safety, efficacy, and optimal dosage of new drugs or medical treatments. This includes all phases of clinical research, from early-stage Phase I trials to late-stage Phase III trials, involving testing on volunteers and patients.

Innovating new medical devices or improving existing ones to enhance diagnosis, treatment, or patient care. This can involve designing advanced surgical instruments, diagnostic tools, or wearable health monitoring devices.

Researching and developing biotechnological solutions such as gene therapy, monoclonal antibodies, or CRISPR-based treatments. This includes projects aimed at manipulating biological systems or organisms to develop new therapies or diagnostic techniques.

Innovating in the formulation of pharmaceutical products to enhance drug stability, bioavailability, or patient compliance. This includes developing novel drug delivery systems like nanoparticles, transdermal patches, or sustained-release formulations.

Developing digital health technologies that support healthcare delivery, such as telemedicine platforms, health data analytics tools, or mobile health applications. Projects may also involve integrating AI or machine learning to enhance healthcare solutions.

Advancing personalized medicine approaches that tailor treatments based on individual genetic profiles. This can involve research into genetic markers, the development of personalized drug regimens, or innovations in precision oncology.

Innovating in the fields of regenerative medicine and tissue engineering to develop therapies that repair or replace damaged tissues and organs. This includes research into stem cell therapy, tissue scaffolds, and bioengineering techniques.

Enhancing pharmaceutical manufacturing processes to increase efficiency, quality, and compliance. Projects may involve the development of continuous manufacturing techniques, process automation, or advanced quality control methods.

Investigating potential drug interactions, side effects, or long-term impacts of pharmaceutical products. This includes conducting post-market surveillance studies and developing methods to mitigate adverse effects or enhance drug safety.

How Can Walmer Help

  • R&D Tax Relief

    Research & Development Tax Reliefs support companies that carry out innovative projects or develop solutions to challenges faced in their industry.

    Click to find out more

  • Grants

    Grants are funds made available by private or public bodies such as UKRI to help finance innovative projects at various stages of R&D

    Click to find out more

  • Financing Solutions

    R&D Advance Loans are an alternative financing option that enables companies to receive their pending R&D Tax Relief benefit in advance

    Click to find out more

  • Investor Relations

    By having a deep insight of our clients’ business through our R&D & Grants consulting services as well as the finance product, combined with a wide array of corporate partnerships, we are able to assist clients with capital introductions to investors most relevant to them.

    Click to find out more

  • R&D Tax Relief

    Research & Development Tax Reliefs support companies that carry out innovative projects or develop solutions to challenges faced in their industry.

    Click to find out more

  • Grants

    Grants are funds made available by private or public bodies such as UKRI to help finance innovative projects at various stages of R&D

    Click to find out more

  • Financing Solutions

    R&D Advance Loans are an alternative financing option that enables companies to receive their pending R&D Tax Relief benefit in advance

    Click to find out more

  • Investor Relations

    By having a deep insight of our clients’ business through our R&D & Grants consulting services as well as the finance product, combined with a wide array of corporate partnerships, we are able to assist clients with capital introductions to investors most relevant to them.

    Click to find out more